Literature DB >> 21850018

SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.

María R Girotti1, Marisol Fernández, Juan A López, Emilio Camafeita, Elmer A Fernández, Juan P Albar, Lorena G Benedetti, María P Valacco, Rolf A Brekken, Osvaldo L Podhajcer, Andrea S Llera.   

Abstract

In melanoma, the extracellular protein SPARC (secreted protein acidic and rich in cysteine) is related to tumor progression. Some of the evidence that links SPARC to melanoma progression indicates that SPARC may be involved in the acquisition of mesenchymal traits that favor metastatic dissemination. However, no molecular pathways that link extracellular SPARC to a mesenchymal phenotype have been described. In this study, global protein expression analysis of the melanoma secretome following enforced downregulation of SPARC expression led us to elucidate a new molecular mechanism by which SPARC promotes cathepsin B-mediated melanoma invasiveness using collagen I and α2β1 integrins as mediators. Interestingly, we also found that the transforming growth factor (TGF)-β1 contribution to cathepsin B-mediated invasion is highly SPARC dependent. In addition, induction of the E-cadherin to N-cadherin switch by SPARC enabled melanoma cells to transmigrate across an endothelial layer through a mechanism independent to that of enhancing invasion. Finally, SPARC also enhanced the extracellular expression of other proteins involved in epithelial-mesenchymal transformation, such as family with sequence similarity 3, member C/interleukin-like EMT-inducer. Our findings demonstrate a previously unreported molecular pathway for SPARC activity on invasion and support an active role of SPARC in the mesenchymal transformation that contributes to melanoma dissemination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21850018     DOI: 10.1038/jid.2011.239

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  29 in total

1.  Integrin β4 regulates SPARC protein to promote invasion.

Authors:  Kristin D Gerson; Jeffrey R Shearstone; V S R Krishna Maddula; Bruce E Seligmann; Arthur M Mercurio
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

2.  Dissection of the human multipotent adult progenitor cell secretome by proteomic analysis.

Authors:  Gregory G Burrows; Wouter Van't Hof; Laura F Newell; Ashok Reddy; Phillip A Wilmarth; Larry L David; Amy Raber; Annelies Bogaerts; Jef Pinxteren; Robert J Deans; Richard T Maziarz
Journal:  Stem Cells Transl Med       Date:  2013-08-27       Impact factor: 6.940

3.  Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction.

Authors:  Zhengfa Mao; Xiaoyan Ma; Xin Fan; Lei Cui; Ting Zhu; Jianguo Qu; Jianxin Zhang; Xuqing Wang
Journal:  Tumour Biol       Date:  2014-07-16

Review 4.  Cathepsin B as a cancer target.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

5.  Re-sensitization of 5-FU resistance by SPARC through negative regulation of glucose metabolism in hepatocellular carcinoma.

Authors:  Hong-Wei Hua; Feng Jiang; Qian Huang; Zhi-Jun Liao; Gang Ding
Journal:  Tumour Biol       Date:  2014-09-25

Review 6.  Cathepsin B: multiple roles in cancer.

Authors:  Neha Aggarwal; Bonnie F Sloane
Journal:  Proteomics Clin Appl       Date:  2014-03-26       Impact factor: 3.494

7.  Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma.

Authors:  Yuqing Lou; Rong Li; Jielin Liu; Yanwei Zhang; Xueyan Zhang; Bo Jin; Ya Liu; Zuoguang Wang; Hua Zhong; Shaojun Wen; Baohui Han
Journal:  Med Oncol       Date:  2015-03-22       Impact factor: 3.064

Review 8.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

9.  Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).

Authors:  Begoña Martin-Castillo; Cristina Oliveras-Ferraros; Alejandro Vazquez-Martin; Silvia Cufí; José Manuel Moreno; Bruna Corominas-Faja; Ander Urruticoechea; Ángel G Martín; Eugeni López-Bonet; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

10.  Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis.

Authors:  Jie Chen; Dehuan Shi; Xiaoyan Liu; Shuang Fang; Jie Zhang; Yueran Zhao
Journal:  BMC Cancer       Date:  2012-10-10       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.